{"schema_version":"secwatch.filing_event.v1","accession":"0001372514-24-000057","form_type":"8-K","ticker":"KPRX","cik":"0001372514","company_name":"KIORA PHARMACEUTICALS INC","filed_at":"2024-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.135260+00:00","generated_at":"2026-06-01T05:30:25.351887+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Kiora Pharmaceuticals announces 1-for-9 reverse stock split effective June 11, 2024 to meet Nasdaq bid price requirement","bullets":["1-for-9 reverse stock split filed June 6, 2024; effective at open of market on June 11, 2024.","Outstanding shares will reduce from ~26.7M to ~2.97M; fully diluted from ~100.1M to ~11.1M.","Class D warrants for 3.43M shares expired on June 6, 2024; other warrants adjust proportionally.","No change to authorized shares, par value ($0.01), or ticker (KPRX); fractional shares paid in cash.","Reverse split is intended to maintain compliance with Nasdaq minimum bid price requirement."],"urls":{"canonical":"https://secwatch.observer/filing/0001372514-24-000057","json":"https://secwatch.observer/filing/0001372514-24-000057.json","markdown":"https://secwatch.observer/filing/0001372514-24-000057.md","text":"https://secwatch.observer/filing/0001372514-24-000057.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1372514/000137251424000057/0001372514-24-000057-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1372514/000137251424000057/kprx-20240606.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:30:25.351887+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}